SCHEMBL24601799

SCHEMBL24601799

c1ccc(-c2cc(-c3ccccc3)c(-c3ccc4c5c6c7ccccc7n7c8cc(-c9c(-c%10ccccc%10)cc(-c%10ccccc%10)cc9-c9ccccc9)ccc8c(c8c9ccccc9n(c4c3)c85)c67)c(-c3ccccc3)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.34
MAOB P27338 1/20 0.33
RXRA P19793 1/20 0.32
RXRB P28702 1/20 0.32
PTPN1 P18031 1/20 0.31
KDM4E B2RXH2 2/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
MAPT P10636 1/20 0.31
RECQL P46063 1/20 0.31
PLEC Q15149 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
LIMK1 P53667 1/20 0.31
GPR84 Q9NQS5 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
CHEK1 O14757 1/20 0.30
WEE1 P30291 1/20 0.30
LMNA P02545 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24601804 0.93 TSPO (0.35) HSD17B10PTPN1GPR84CHEK1WEE1
SCHEMBL24601800 0.90 GPR84 (0.37) HSD17B10MAOBKDM4EKMT2AMEN1
SCHEMBL24601423 0.90 HSD17B10 (0.35) HSD17B10MAOBKDM4EKMT2AMEN1
SCHEMBL24601624 0.90 HSD17B10 (0.35) HSD17B10MAOBKDM4EKMT2AMEN1
SCHEMBL24601656 0.88 KDM4E (0.35) HSD17B10MAOBRXRARXRBKDM4E
SCHEMBL24601497 0.87 HSD17B10 (0.35) HSD17B10MAOBKDM4EKMT2AMEN1
SCHEMBL24601437 0.86 MAOB (0.39) HSD17B10MAOBRXRARXRBKDM4E
SCHEMBL22178597 0.86 MAOB (0.41) HSD17B10MAOBRXRARXRBKDM4E
SCHEMBL24601426 0.86 MAOB (0.35) HSD17B10MAOBRXRARXRBPTPN1
SCHEMBL24601494 0.86 MAOB (0.35) HSD17B10MAOBRXRARXRBPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220213113-A1 NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES NCL, NOC2L, NOLC1 HSD17B10 4661/4885MAOB 2002/4885RXRA 4654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.